Literature DB >> 11440744

Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation.

S Schmidt1, L Wessels, A Augustin, T Klockgether.   

Abstract

Recent models of experimental autoimmune encephalomyelitis (EAE) have indicated that antigens co-expressed in the retina and uvea might be of pathogenetic relevance in Multiple Sclerosis (MS). We investigated the clinical spectrum and magnetic resonance imaging of 11 MS patients with concomitant uveitis, and determined the frequency of clinically silent intraocular inflammation in a prospective series of 50 patients. Two of the 11 patients had panuveitis, seven had anterior, and the remaining two had intermediate uveitis. The onset of uveitis preceded that of neurological symptoms by a mean of 8.5 years (range 1-20). None of the 50 MS patients studied prospectively by using slit lamp examinations and dilated funduscopy showed any evidence of uveitis but six patients had signs of retinal inflammation ("periphlebitis retinae"). Cranial MRI did not reveal "atypical" lesional distribution in MS patients with uveitis or periphlebitis retinae. No correlation between the type of MS and uveitis, or between the degree of neurological disability and the type of uveitis was found.

Entities:  

Mesh:

Year:  2001        PMID: 11440744     DOI: 10.1016/s0022-510x(01)00520-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.

Authors:  R A Marrie; R Rudick; R Horwitz; G Cutter; T Tyry; D Campagnolo; T Vollmer
Journal:  Neurology       Date:  2010-03-30       Impact factor: 9.910

Review 2.  The retrovirus/superantigen hypothesis of multiple sclerosis.

Authors:  Alexander Emmer; Martin S Staege; Malte E Kornhuber
Journal:  Cell Mol Neurobiol       Date:  2014-08-20       Impact factor: 5.046

3.  Association between comorbidity and clinical characteristics of MS.

Authors:  R A Marrie; R I Horwitz; G Cutter; T Tyry; T Vollmer
Journal:  Acta Neurol Scand       Date:  2010-09-29       Impact factor: 3.209

4.  Uveitis associated with multiple sclerosis: complications and visual prognosis.

Authors:  Derya Kaya; Mahmut Kaya; Serkan Özakbaş; Egemen İdiman
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

5.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.

Authors:  Ari J Green; Stephen McQuaid; Stephen L Hauser; Ingrid V Allen; Roy Lyness
Journal:  Brain       Date:  2010-04-21       Impact factor: 13.501

6.  Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.

Authors:  Eyal Raskin; Anat Achiron; Ofira Zloto; Ron Neuman; Vicktoria Vishnevskia-Dai
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

7.  Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

8.  Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center.

Authors:  Thomas Ness; Daniel Boehringer; Sonja Heinzelmann
Journal:  Orphanet J Rare Dis       Date:  2017-04-27       Impact factor: 4.123

9.  Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Authors:  D Coric; G Ometto; G Montesano; P A Keane; L J Balk; B M J Uitdehaag; A Petzold; D P Crabb; A K Denniston
Journal:  Eur J Neurol       Date:  2019-08-18       Impact factor: 6.089

10.  Ipsilateral uveitis and optic neuritis in multiple sclerosis.

Authors:  Eric Thouvenot; Frédéric Mura; Marie De Verdal; Bertrand Carlander; Mahmoud Charif; Christelle Schneider; Sophie Navarre; William Camu
Journal:  Mult Scler Int       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.